Bo Martin Bibby

Response of fibroblast growth factor 21 to meal intake and insulin infusion in patients on maintenance haemodialysis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

OBJECTIVE: To investigate the response of serum fibroblast growth factor 21 (FGF21) to a meal and to insulin infusion in haemodialysis (HD) patients.

DESIGN AND PATIENTS: Meal study: in a cross-over design, 12 non-diabetic HD patients were randomly assigned to: 1) a non-HD day with one meal served, 2) a HD day with one meal served during HD, and 3) a HD day with two meals served during and after HD, respectively. Twelve healthy controls participated in an experiment identical to the non-HD day. Insulin infusion study: in a cross-over design, 11 non-diabetic HD patients were randomly assigned to receive a 4-h HD session with either: 1) no infusion, 2) glucose infusion, or 3) glucose-insulin infusion. A meal was served 2 h before HD start.

RESULTS: Meal study: serum FGF21 was 23-fold higher in HD patients than controls (P < 0∙001). Postprandial FGF21 decreased on all four study days (P ˂ 0∙006), but the relative reductions from baseline were significantly greater in controls (P < 0∙008). Postprandial changes in FGF21 were inversely related with triglycerides (P = 0∙042) and positively related with insulin-like growth factor binding protein-1 (IGFBP-1) (P < 0∙001). Serum FGF21 was only associated with changes in adiponectin (P = 0∙001) and free fatty acids (P = 0∙04) in the healthy controls. Insulin infusion study: as compared with no infusion, glucose and glucose-insulin infusion prevented the postprandial decrease in FGF21 and resulted in higher FGF21 concentrations by up to 25% (P = 0∙003).

CONCLUSIONS: Serum FGF21 was highly elevated in HD patients but the response of serum FGF21 to meal intake and insulin infusion seemed to be intact. Our results indicate that FGF21 may play an important role in short-term metabolic homeostasis. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalClinical Endocrinology
Volume83
Issue2
Pages (from-to)187-95
Number of pages9
ISSN0300-0664
DOIs
Publication statusPublished - Aug 2015

See relations at Aarhus University Citationformats

ID: 85143614